Polymorph forms of (2S) - (4E) -Nmethyl-5- (3-isopropoxypyridin) yl] -4penten-2-amine for the treatment of central nervous system disorders

Details for Australian Patent Application No. 2007249485 (hide)

Owner Targacept, Inc.

Inventors Munoz, Julio A.; Dull, Gary Maurice

Agent FB Rice

Pub. Number AU-B-2007249485

PCT Pub. Number WO2007/134034

Priority 60/746,821 09.05.06 US

Filing date 8 May 2007

Wipo publication date 22 November 2007

Acceptance publication date 1 November 2012

International Classifications

C07D 213/63 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/44 - Non-condensed pyridines

A61P 25/28 Drugs for disorders of the nervous system

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2007/134034 Priority application(s): WO2007/134034

1 November 2012 Application Accepted

  Published as AU-B-2007249485

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007249488-Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments

2007249477-Oral care implement